Infinity Pharmaceuticals Inc (INFI):企業の財務・戦略的SWOT分析

◆英語タイトル:Infinity Pharmaceuticals Inc (INFI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15907
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Infinity Pharmaceuticals Inc (INFI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company that discovers and develops small molecule therapeutics for the treatment of cancer. The company’s pipeline candidate: IPI-549 selectively inhibits PI3K-gamma to reprogram tumor-associated macrophages and transforms immuno-oncology approach. It is evaluating IPI-549 as a monotherapy in Phase 2 clinical trials for the treatment of a wide range of solid tumors. Infinity Pharmaceuticals is also investigating IPI-549 in Phase 1 clinical studies for the treatment of advanced solid tumors, and in a combination therapy in Phase 1n clinical trials for the treatment of non-small cell lung cancer (NSCLC), melanoma, squamous cell carcinoma of the head and neck (SCCHN), triple negative breast cancer (TNBC), mesothelioma, adrenocortical carcinoma, and myeloid-derived suppressor cells (MDSC). Infinity Pharmaceuticals is headquartered in Cambridge, Massachusetts, the US.

Infinity Pharmaceuticals Inc Key Recent Developments

Mar 14,2019 Infinity Pharmaceuticals reports full year 2018 financial results and provides company update
Nov 07,2018 Bristol-Myers and Infinity partner for trial of opdivo and IPI-549
Nov 05,2018 Infinity Pharmaceuticals announces third quarter 2018 financial results
Aug 07,2018 Infinity Pharmaceuticals provides company update and second quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Infinity Pharmaceuticals Inc – Key Facts
Infinity Pharmaceuticals Inc – Key Employees
Infinity Pharmaceuticals Inc – Key Employee Biographies
Infinity Pharmaceuticals Inc – Major Products and Services
Infinity Pharmaceuticals Inc – History
Infinity Pharmaceuticals Inc – Company Statement
Infinity Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Infinity Pharmaceuticals Inc – Business Description
R&D Overview
Infinity Pharmaceuticals Inc – Corporate Strategy
Infinity Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Infinity Pharmaceuticals Inc – Strengths
Infinity Pharmaceuticals Inc – Weaknesses
Infinity Pharmaceuticals Inc – Opportunities
Infinity Pharmaceuticals Inc – Threats
Infinity Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Infinity Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 14, 2019: Infinity Pharmaceuticals reports full year 2018 financial results and provides company update
Nov 07, 2018: Bristol-Myers and Infinity partner for trial of opdivo and IPI-549
Nov 05, 2018: Infinity Pharmaceuticals announces third quarter 2018 financial results
Aug 07, 2018: Infinity Pharmaceuticals provides company update and second quarter 2018 financial results
Aug 07, 2018: Infinity Pharmaceuticals appoints Samuel Agresta as Chief Medical Officer
May 08, 2018: Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results
Mar 08, 2018: Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team and Establishes Scientific Advisory Board
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Infinity Pharmaceuticals Inc, Key Facts
Infinity Pharmaceuticals Inc, Key Employees
Infinity Pharmaceuticals Inc, Key Employee Biographies
Infinity Pharmaceuticals Inc, Major Products and Services
Infinity Pharmaceuticals Inc, History
Infinity Pharmaceuticals Inc, Subsidiaries
Infinity Pharmaceuticals Inc, Key Competitors
Infinity Pharmaceuticals Inc, Ratios based on current share price
Infinity Pharmaceuticals Inc, Annual Ratios
Infinity Pharmaceuticals Inc, Annual Ratios (Cont...1)
Infinity Pharmaceuticals Inc, Interim Ratios
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Infinity Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Infinity Pharmaceuticals Inc, Performance Chart (2014 - 2018)
Infinity Pharmaceuticals Inc, Ratio Charts
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Infinity Pharmaceuticals Inc (INFI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Texas Health Resources:企業の戦略的SWOT分析
    Texas Health Resources - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • China Biologic Products Inc (CBPO):製薬・医療:M&Aディール及び事業提携情報
    Summary China Biologic Products Inc (China Biologic) is a biopharmaceutical company that offers plasma collection, research and development, production, commercialization of biopharmaceutical products and development of treatment products. The company manufactures, develops, and markets biologic pro …
  • PIQUR Therapeutics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary PIQUR Therapeutics AG (PIQUR) is a developer of anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipeline products comprise PQR-309, PQR-620, PQR-530, PQR …
  • Quatrro BPO Solutions (P), Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Quatrro BPO Solutions (P), Ltd. …
  • Power-One, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Power-One, Inc. Mergers and Acq …
  • Revolution Lighting Technologies, Inc. (RVLT):企業概要、財務及び戦略的SWOT分析
    Summary Revolution Lighting Technologies, Inc. (Revolution) formerly Nexxus Lighting, Inc., is a lighting equipment manufacturer. The company designs, manufactures and markets lighting products. Its products include interior illumination products, signage and accent lighting, exterior illumination p …
  • FirstGroup plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' FirstGroup plc Mergers and Acqu …
  • Oxurion NV (THR):製薬・医療:M&Aディール及び事業提携情報
    Summary Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreo …
  • Feelgood Svenska AB (FEEL):企業概要、財務及び戦略的SWOT分析
    Summary Feelgood Svenska AB (Feelgood Svenska) is a healthcare service provider. The company provides healthcare services to businesses, organizations, and individuals. It offers medical services, primary care, exercise, and physical therapy. Feelgood Svenska offers services in the areas of sustaina …
  • Linde India Limited (LINDEINDIA):企業概要、財務及び戦略的SWOT分析
    Summary Linde India Limited (Linde) is an industrial gas company. The company offers gases and mixtures, and related services. Its services include designing, supply, installation and commissioning of tonnage air separation units, pressure swing adsorption plants and gas distribution systems. Linde …
  • Al Baraka Banking Group B.S.C.:企業の戦略・SWOT・財務分析
    SummaryAl Baraka Banking Group B.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • Suncor Energy Inc (SU):石油・ガス:M&Aディール及び事業提携情報
    Summary Suncor Energy Inc (Suncor) is an integrated energy company that mainly focuses on the development of Athabasca oil sands. It carries out development and up gradation of oil sands; offshore and onshore oil and gas production; refining of crude oil and marketing of petroleum and petrochemical …
  • PetroEnergy Resources Corporation (PERC):企業の財務及び戦略的SWOT分析
    Summary PetroEnergy Resources Corporation (PERC) is an upstream oil company that explores and develops oil and mineral properties. The company holds 2.52% interest in the Etame Marin permit in offshore Gabon, West Africa. Its Etame Marin permit encompasses 3,074 sq. km of the northern Congo basin, r …
  • Altona Energy plc (ANR):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Altona Energy plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows …
  • Associated Petroleum Products Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Associated Petroleum Products Inc (APP), a subsidiary of World Fuel Services Corp is an oil and gas company that offers petroleum products. The company provides products such as commercial fuel, aviation fuel, fuels, heating oil, lube oil, fuel additives, propane, marine lubricants and equip …
  • The Laclede Group, Inc.:企業の戦略・SWOT・財務分析
    The Laclede Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Laclede Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • JVC Kenwood Corporation (6632):企業の財務及び戦略的SWOT分析
    Summary JVC Kenwood Corporation (JVC Kenwood ) is an electronic products company that manufactures and sells electronic and entertainment products. The company specializes in manufacturing and selling of car audio products, car AV systems, car navigation systems, and related products. JVC Kenwood al …
  • Centrum Nowoczesnych Technologii S.A. (CNT):企業財務及び戦略的SWOT分析
    Summary Centrum Nowoczesnych Technologii S.A. (CNT) formerly Energopol – Poludnie S.A is a construction company that offers deconstruction and demolition of industrial objects. The company offers road works, high capacity objects and general construction roads; environmental engineering, demolitions …
  • JSC Synergy:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JSC Synergy Mergers and Acquisi …
  • Weizmann Limited (WEIZMANIND):企業概要、財務及び戦略的SWOT分析
    Summary Weizmann Limited (Weizmann) is a textile processing and manufacturing company. The company exports textiles to African countries. Its product portfolio comprises cotton voiles, pracale, and African prints. Weizmann carries out its activities such as grey cloth, inspection of grey fabric, ble …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆